Bookimed does not add extra charges for Immunotherapy with Keytruda (Pembolizumab) prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Immunotherapy with Keytruda (Pembolizumab) upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
Germany | Turkey | Austria | |
Immunotherapy with Keytruda (Pembolizumab) | from $6,877 | from $7,300 | - |
Asklepios Hospital Barmbek holds the No. 1 ranking for foreign patients by the Medical Travel Quality Alliance. The hospital offers immunotherapy with Keytruda (Pembrolizumab) within its advanced oncology department. The facility treats 80,000 patients annually, ensuring high standards and safety with a DIN EN ISO 9001: 2015 certification. The multidisciplinary team approach ensures precise treatment plans. Located 8 km from Hamburg's central square, patients can explore nearby attractions during their stay.
Asklepios St. Georg Hospital ranks among Germany's top medical facilities by Focus magazine. The hospital treats 87,000 patients annually, ensuring high-quality care. It holds 18 awards and certificates, including the DIN EN ISO 9001: 2015 Quality Certificate. Located near Lohmühlen-Grünzug Park in Hamburg, it offers convenient access to sights. The hospital's affiliation with the Research Center of Hamburg University supports innovative treatments, including immunotherapy with Keytruda (Pembrolizumab), managed by world-renowned doctors.
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.